Back to search
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The current study is being conducted to assess the efficacy and safety of KIg10 (Intravenous Human Immune globulin 10%) at two different dosages as maintenance…
Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
The main purpose of this study is to evaluate the safety and efficacy of nipocalimab compared to placebo in delaying relapse in adults with chronic inflammatory…
This is a Phase 2b study to evaluate the efficacy and safety of Imeroprubart in adults with CIDP.
Neurological autoimmune diseases are a group of disorders characterized by the abnormal immune response attacking the nervous system, including the brain, spina…
The purpose of the study is to evaluate efficacy of riliprubart compared to IVIg in adult participants with CIDP who are receiving maintenance treatment with IV…
This is a multi-center, randomized, quadruple-blind, placebo-controlled study to evaluate the efficacy and safety of batoclimab in adult participants with activ…
This is an open-label extension (OLE) study designed to evaluate the long-term safety and tolerability of batoclimab in participants with CIDP who have complete…